Lungpacer Medical Nominated for 2026 Prix Galien USA Award for Best Medical Technology
Nomination by the Prix Galien Foundation recognizes the AeroPace® System, the first FDA-approved diaphragm neurostimulation therapy to help critically ill patients breathe on their own again EXTON, Pa., Aug.
19, 2026 (GL
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.